Development of Fast Dissolving Carbamazepine Tablets: Effect of Functionality of Superdisintegrants

DOI:

https://doi.org/10.37285/ijpsn.2010.3.1.5

Authors

  • N. G. Raghavendra Rao
  • Tarun Patel
  • Rathan Kumar

Abstract

Carbamazepine, a dibenzapine derivative with structure resembling that of tricyclic antidepressants, is used in the treatment of epilepsy. The major problem of this drug is very low solubility in biological fluids and poor bioavailability after oral administration. Carbamazepine fast dissolving tablets (FDT) have been prepared by direct compression method. Effects of superdisintegrants (such as croscarmellose sodium, crospovidone and sodium starch glycolate) on wetting time, disintegrating time, drug content, in vitro release, and stability parameters have been studied. The prepared tablets were characterized by DSC and FTIR Studies. No chemical interaction between drug and excipients was confirmed by DSC and FTIR studies. Disintegration time and dissolution parameters (t50% and t90%) decreased with increase in the level of croscarmellose sodium and crosspovidone, whereas disintegration time and dissolution parameters increased with increase in the level of the sodium starch glycolate in tablets. Among all formulations f8 was considered best. The results concluded that fast dissolving tablets of poorly soluble drug carbamazepine, showing enhanced dissolution, will lead to improved bioavailability, improved effectiveness and hence better patient compliance.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Fast dissolving tablets, Carbamazepine, croscarmellose sodium, crospovidone and sodium starch glycolate

Downloads

Published

2010-05-31

How to Cite

1.
Rao NGR, Patel T, Kumar R. Development of Fast Dissolving Carbamazepine Tablets: Effect of Functionality of Superdisintegrants. Scopus Indexed [Internet]. 2010 May 31 [cited 2024 Sep. 8];3(1):824-33. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/473

Issue

Section

Research Articles

References

Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996; 44: 2121-2127.

Bolhuis GK, Zuurman K, Te Wierik GH. Improvement of dissolution of poorly soluble drugs by solid deposition on a superdisintegrant: II, The choice of superdisintegrants and effect of granulation. Eur J Pharm Sci 1997; 5: 63-9.

Chang RK, Guo X, Burnside B, Couch R. Fast dissolving tablets. Pharm Technol 2000; 24:52-8.

Dobetti L. Fast-melting tablets: Developments and technologies. Pharm Technol Eur 2000; 12:32-42.

Indian Pharmacopoeia, 4th Edn., Controller of publications, India, New Delhi, 1996, A-80.

Martin A, editor. Physical pharmacy. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 1993. p. 324-62.

McNaman JO, Hardman JG, Limbird LE, Molinoff PB, and Ruddon RW. Eds., The Pharmacological Basis of Therapeutics: 9th Edn. Mc Graw-Hill, New York, 1996, 46.

Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Tarada K. Formulation design of a novel fast-disintegrating tablet. Int J Pharm 2005; 306:83-90.

Patrick K, Sang KW. Method of making freeze-dried dosage form. US Patent 5 631 023; 1997.

Reynolds JEF, Eds., In; Martindale; The Extra Pharmacopoeia, 29th Edn., The Royal Pharmaceutical Society of Great Britain, London, 1993, 295.

Rowe RC, Sheskey PJ, Weeler PJ, editors. Handbook of pharmaceutical excipients. 4th ed. London and Washington DC: The Pharmaceutical Press; 2003.

Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 2002; 15:295-305.

Setty CM, Prasad DVK, Gupta VRM, Sa B. Development of Fast dispersible Aceclofenac tablets: Effect of functionality of superdisintegrants. Indian J Pharm Sci., 2008; 70(2): 180-185.

Sunada H, Bi YX, Yonezawa Y, Danjo K. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002; 122:188-98.

Takao M, Yoshinori M, Muneo F. Intra buccally dissolving compressed mouldings and production process thereof. US patent 5 576 014; 1996.

Virley P, Yarwood R. Zydis. A novel fast dissolving dosage form. Manuf Chem 1990; 61: 22-9.

United States Pharmacopoeia. Rockville. MD: 27 th revision. USP Convention, Inc.; 2004. p. 2302.

Zhao N, Augsburger LL. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution. AAPS Pharm Sci Tech 2005; 6: Article 79.

Yunxia B, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapid disintegrating tablets prepared by direct compression method. Drug Dev Ind Pharm 1999;25:571.